دورية أكاديمية
أعرض في EDS

Emotional distress and future healthcare utilization in oncology populations: A systematic review.

التفاصيل البيبلوغرافية
العنوان: Emotional distress and future healthcare utilization in oncology populations: A systematic review.
المؤلفون: Kirsch JL; Mayo Clinic, Rochester, Minnesota, USA., Roche AI; Mayo Clinic, Rochester, Minnesota, USA., Bronars C; Mayo Clinic, Rochester, Minnesota, USA., Donovan KA; Mayo Clinic, Rochester, Minnesota, USA., Hassett LC; Mayo Clinic, Rochester, Minnesota, USA., Ehlers SL; Mayo Clinic, Rochester, Minnesota, USA.
المصدر: Psycho-oncology [Psychooncology] 2024 Mar; Vol. 33 (3), pp. e6322.
نوع المنشور: Systematic Review; Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9214524 Publication Model: Print Cited Medium: Internet ISSN: 1099-1611 (Electronic) Linking ISSN: 10579249 NLM ISO Abbreviation: Psychooncology Subsets: In Process
أسماء مطبوعة: Original Publication: Chichester, W. Sussex, England : Wiley, c1992-
مستخلص: Objective: Emotional distress has been correlated with greater healthcare utilization and economic costs in cancer; however, the prospective relationship between positive distress screens and future healthcare utilization is less clear. Taken together, there is a critical need to synthesize studies examining the prospective relationship between emotional distress and future healthcare use to inform distress management protocols and motivate institutional resource allocation to distress management. The aim of the systematic review is to explore the relationship between emotional distress, measured via validated emotional distress questionnaires, and subsequent healthcare utilization in patients diagnosed with cancer.
Methods: A systematic search of seven databases was conducted on 29 March 2022 and updated 3 August 2023. Eligibility criteria were: (1) peer-reviewed, (2) quantitative or mixed methods, (3) adults (≥18 years) diagnosed with cancer, (4) cancer distress questionnaire(s) completed prior to healthcare utilization, and (5) written in English. Exclusion criteria included: (1) non-emotional aspects of distress (i.e., spiritual or physical distress), (2) healthcare utilization characterized via economic or monetary variables, and (3) caregiver or non-cancer populations.
Results: Nineteen peer-reviewed articles were included in the review. There was significant heterogeneity in emotional distress instruments and type of healthcare utilization used. Most studies examining general distress or anxiety found that increased distress was predictive of greater future healthcare utilization.
Conclusion: The results suggest that individuals with higher levels of general distress and anxiety are at increased risk for future healthcare utilization.
(© 2024 John Wiley & Sons Ltd.)
References: Riba MB, Donovan KA, Ahmed K, et al. NCCN Guidelines® insights: distress management, version 2.2023: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2023;21(5):450-457. https://doi.org/10.6004/jnccn.2023.0026.
Riba MB, Donovan KA, Andersen B, et al. Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw J Natl Compr Canc Netw. 2019;17(10):1229-1249. https://doi.org/10.6004/jnccn.2019.0048.
Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605-1619. https://doi.org/10.1200/jco.2013.52.4611.
Pirl W, Nekhlyudov L, Rowland JH, Lacchetti C, Andersen BL. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update Q&A. JCO Oncol Pract. 2023;19(9):714-717. https://doi.org/10.1200/op.23.00324.
Andersen BL, Lacchetti C, Ashing K, et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol. 2023;41(18):3426-3453. https://doi.org/10.1200/jco.23.00293.
Williams JTW, Pearce A, Smith AB. A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psycho Oncol. 2021;30(8):1185-1195. https://doi.org/10.1002/pon.5673.
Van Beek FE, Wijnhoven LM, Holtmaat K, et al. Psychological problems among cancer patients in relation to healthcare and societal costs: a systematic review. Psycho Oncol. 2021;30(11):1801-1835. https://doi.org/10.1002/pon.5753.
Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007;25(29):4670-4681. https://doi.org/10.1200/jco.2006.10.0438.
Dai D, Coetzer H, Zion SR, Malecki MJ. Anxiety, depression, and stress reaction/adjustment disorders and their associations with healthcare resource utilization and costs among newly diagnosed patients with breast cancer. J Health Econ Outcomes Res. 2023;10(1):68-76. https://doi.org/10.36469/jheor.2023.70238.
Davis NE, Hue JJ, Kyasaram RK, et al. Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer. Psycho Oncol. 2022;31(8):1390-1398. https://doi.org/10.1002/pon.5945.
Elsamadicy AA, Koo AB, Sarkozy M, et al. Differences in health care resource utilization after surgery for metastatic spinal column tumors in patients with a concurrent affective disorder in the United States. World Neurosurg. 2022;161:e252. https://doi.org/10.1016/j.wneu.2022.01.112.
Khushalani JS, Qin J, Cyrus J, et al. Systematic review of healthcare costs related to mental health conditions among cancer survivors. Expert Rev Pharmacoecon Outcomes Res. 2018;18(5):505-517. https://doi.org/10.1080/14737167.2018.1485097.
Doll KM, Barber EL, Bensen JT, Snavely AC, Gehrig PA. The health-related quality of life journey of gynecologic oncology surgical patients: implications for the incorporation of patient-reported outcomes into surgical quality metrics. Gynecol Oncol. 2016;141(2):329-335. https://doi.org/10.1016/j.ygyno.2016.03.003.
Hildenbrand JD, Park HS, Casarett DJ, et al. Patient-reported distress as an early warning sign of unmet palliative care needs and increased healthcare utilization in patients with advanced cancer. Support Care Cancer. 2022;30(4):3419-3427. https://doi.org/10.1007/s00520-021-06727-3.
Nipp RD, El-Jawahri A, D'Arpino SM, et al. Symptoms of posttraumatic stress disorder among hospitalized patients with cancer. Cancer. 2018;124(16):3445-3453. https://doi.org/10.1002/cncr.31576.
Nipp RD, El-Jawahri A, Moran SM, et al. The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer. Cancer. 2017;123(23):4720-4727. https://doi.org/10.1002/cncr.30912.
Schwartz MD, Lerman C, Brogan B, et al. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1003-1007. https://doi.org/10.1158/1055-9965.epi-03-0545.
Waller A, Williams A, Groff SL, Bultz BD, Carlson LE. Screening for distress, the sixth vital sign: examining self-referral in people with cancer over a one-year period. Psycho Oncol. 2013;22(2):388-395. https://doi.org/10.1002/pon.2102.
McDowell ME, Occhipinti S, Ferguson M, Chambers SK. Prospective predictors of psychosocial support service use after cancer. Psycho Oncol. 2011;20(7):788-791. https://doi.org/10.1002/pon.1774.
Lo C, Calzavara A, Kurdyak P, et al. Depression and use of health care services in patients with advanced cancer. Can Fam Physician. 2013;59(3):e168-e174.
Champagne A, Ivers H, Savard J. Utilization of health care services in cancer patients with elevated fear of cancer recurrence. Psycho Oncol. 2018;27(8):1958-1964. https://doi.org/10.1002/pon.4748.
Arch JJ, Mitchell JL, Genung SR, et al. Randomized trial of acceptance and commitment therapy for anxious cancer survivors in community clinics: outcomes and moderators. J Consult Clin Psychol. 2021;89(4):327-340. https://doi.org/10.1037/ccp0000630.
Jeppesen MM, Bergholdt SH, Bentzen AG, et al. Cancer worry is associated with increased use of supportive health care-results from the multinational InCHARGE study. J Cancer Surviv. 2023;18(1):165-175. https://doi.org/10.1007/s11764-023-01337-w.
Compen F, Adang E, Bisseling E, Van der Lee M, Speckens A. Exploring associations between psychiatric disorder, psychological distress, and health care utilization in cancer patients. Psycho Oncol. 2018;27(3):871-878. https://doi.org/10.1002/pon.4591.
Faller H, Weis J, Koch U, et al. Utilization of professional psychological care in a large German sample of cancer patients. Psycho Oncol. 2017;26(4):537-543. https://doi.org/10.1002/pon.4197.
Vachon E, Krueger E, Champion VL, Haggstrom DA, Cella D, Cohee AA. The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials. Psycho Oncol. 2021;30(3):279-286. https://doi.org/10.1002/pon.5568.
Trevino KM, Nelson CJ, Saracino RM, Korc-Grodzicki B, Sarraf S, Shahrokni A. Is screening for psychosocial risk factors associated with mental health care in older adults with cancer undergoing surgery? Cancer. 2020;126(3):602-610. https://doi.org/10.1002/cncr.32564.
Otto AK, Soriano EC, Siegel SD, LoSavio ST, Laurenceau JP. Assessing the relationship between fear of cancer recurrence and health care utilization in early-stage breast cancer survivors. J Cancer Surviv. 2018;12(6):775-785. https://doi.org/10.1007/s11764-018-0714-8.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906.
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276-282. https://doi.org/10.11613/bm.2012.031.
Frey Nascimento A, Tondorf T, Rothschild SI, et al. Oncologist recommendation matters!-Predictors of psycho-oncological service uptake in oncology outpatients. Psycho Oncol. 2019;28(2):351-357. https://doi.org/10.1002/pon.4948.
Hamilton J, Kroska EB. Distress predicts utilization of psychosocial health services in oncology patients. Psycho Oncol. 2019;28(1):61-67. https://doi.org/10.1002/pon.4910.
Azizoddin DR, Allsop M, Farah S, et al. Oncology distress screening within predominately Black Veterans: outcomes on supportive care utilization, hospitalizations, and mortality. Cancer Med. 2023;12(7):8629-8638. https://doi.org/10.1002/cam4.5560.
Carlson LE, Waller A, Groff SL, Zhong L, Bultz BD. Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage. Br J Cancer. 2012;107(4):617-625. https://doi.org/10.1038/bjc.2012.309.
Lieb M, Tagay S, Breidenstein A, et al. Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study. BMC Psychol. 2020;8(1):8. https://doi.org/10.1186/s40359-020-0371-3.
Johansson B, Holmberg L, Berglund G, et al. Reduced utilisation of specialist care among elderly cancer patients: a randomised study of a primary healthcare intervention. Eur J Cancer. 2001;37(17):2161-2168. https://doi.org/10.1016/s0959-8049(01)00278-7.
Sikorskii A, Given CW, Chang S, Tam S, Movsas B, Given B. Patient reported outcomes and unscheduled health services use during oral anti-cancer treatment. J Pain Symptom Manag. 2023;65(2):e115. https://doi.org/10.1016/j.jpainsymman.2022.10.003.
Vaughn DM, Johnson PC, Jagielo AD, et al. Factors associated with health care utilization at the end of life for patients with acute myeloid leukemia. J Palliat Med. 2021;03.
Ye S, Williams CP, Gilbert AD, Huang C.-H, Salter TL, Rocque GB. The impact of depression on health care utilization in patients with cancer. J Palliat Med. 2021;24(5):755-759. https://doi.org/10.1089/jpm.2020.0329.
Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients: a multicenter evaluation of the distress thermometer. Cancer. 2005;103(7):1494-1502. https://doi.org/10.1002/cncr.20940.
Löwe B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1-2):86-95. https://doi.org/10.1016/j.jad.2009.06.019.
Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613-621. https://doi.org/10.1176/appi.psy.50.6.613.
Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment. 2011;18(3):263-283. https://doi.org/10.1177/1073191111411667.
Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873-880. https://doi.org/10.1007/s11136-009-9496-9.
Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015;9(3):481-491. https://doi.org/10.1007/s11764-015-0424-4.
Herschbach P, Berg P, Dankert A, et al. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005;58(6):505-511. https://doi.org/10.1016/j.jpsychores.2005.02.007.
Kroenke K, Spitzer RL. The PHQ-9: A New Depression Diagnostic and Severity Measure. Slack Incorporated Thorofare; 2002:509-515.
Hinz A, Mehnert A, Kocalevent R.-D, et al. Assessment of depression severity with the PHQ-9 in cancer patients and in the general population. BMC Psychiatr. 2016;16(1):1-8. https://doi.org/10.1186/s12888-016-0728-6.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.
Linden W, Andrea Vodermaier A, McKenzie R, Barroetavena MC, Yi D, Doll R. The Psychosocial Screen for Cancer (PSSCAN): further validation and normative data. Health Qual Life Outcome. 2009;7(1):1-8. https://doi.org/10.1186/1477-7525-7-16.
Linden W, Yi D, Barroetavena MC, MacKenzie R, Doll R. Development and validation of a psychosocial screening instrument for cancer. Health Qual Life Outcome. 2005;3:1-7. https://doi.org/10.1186/1477-7525-3-54.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. https://doi.org/10.1177/014662167700100306.
Beck AT, Steer RA, Brown G. Beck depression inventory-II. Psychol Assess. 1996.
Ouimette P, Wade M, Prins A, Schohn M. Identifying PTSD in primary care: comparison of the primary care-PTSD screen (PC-PTSD) and the general health questionnaire-12 (GHQ). J Anxiety Disord. 2008;22(2):337-343. https://doi.org/10.1016/j.janxdis.2007.02.010.
Weiss DS. The Impact of Event Scale: Revised. Cross-Cultural Assessment of Psychological Trauma and PTSD. Springer; 2007:219-238.
American Psychiatric Association D, Association AP. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American psychiatric association; 2013.
Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101(21):1464-1488. https://doi.org/10.1093/jnci/djp336.
Schuit AS, Holtmaat K, van Zwieten V, et al. Organizing psycho-oncological care for cancer patients: the patient’s perspective. Front Psychol. 2021;12:1155. https://doi.org/10.3389/fpsyg.2021.625117.
Melton L, Krause D, Sugalski J. Psychology staffing at cancer centers: data from National Comprehensive Cancer Network member institutions. JCO Oncol Pract. 2020;16(11):e1343. https://doi.org/10.1200/op.20.00087.
McGrady ME, Joffe NE, Pai ALH. Earlier pediatric psychology consultation predicts lower stem cell transplantation hospital costs. J Pediatr Psychol. 2018;43(4):434-442. https://doi.org/10.1093/jpepsy/jsx124.
Bujoreanu S, White MT, Gerber B, Ibeziako P. Effect of timing of psychiatry consultation on length of pediatric hospitalization and hospital charges. Hosp Pediatr. 2015;5(5):269-275. https://doi.org/10.1542/hpeds.2014-0079.
Hua M, Lu Y, Ma X, Morrison RS, Li G, Wunsch H. Association between the implementation of hospital-based palliative care and use of intensive care during terminal hospitalizations. JAMA Netw Open. 2020;3(1):e1918675. https://doi.org/10.1001/jamanetworkopen.2019.18675.
Mitchell AJ, Rao S, Vaze A. Can general practitioners identify people with distress and mild depression? A meta-analysis of clinical accuracy. J Affect Disord. 2011;130(1-2):26-36. https://doi.org/10.1016/j.jad.2010.07.028.
Mitchell AJ, Hussain N, Grainger L, Symonds P. Identification of patient-reported distress by clinical nurse specialists in routine oncology practice: a multicentre UK study. Psycho Oncol. 2011;20(10):1076-1083. https://doi.org/10.1002/pon.1815.
Knox-Rice T, Xuan L, Wadsworth H, Halm EA, Rhodes RL. Examining the association between healthcare utilization and clinical characteristics among cancer patients in a safety net health system. J Palliat Med. 2019;22(1):80-83. https://doi.org/10.1089/jpm.2018.0202.
May P, Garrido MM, Aldridge MD, et al. Prospective cohort study of hospitalized adults with advanced cancer: associations between complications, comorbidity, and utilization. J Hosp Med. 2017;12(6):407-413. https://doi.org/10.12788/jhm.2745.
Leggett LE, Khadaroo RG, Holroyd-Leduc J, et al. Measuring resource utilization: a systematic review of validated self-reported questionnaires. Medicine (Baltimore). 2016;95(10):e2759.
Hospital-Wide All-Cause Unplanned Readmission Measure (NQF #1789). National Quality Strategy Domain: Communication and Care Coordination; 2019. https://www.cms.gov/priorities/innovation/files/fact-sheet/bpciadvanced-fs-nqf1789.pdf.
فهرسة مساهمة: Keywords: anxiety; cancer distress; depression; healthcare utilization; psycho-oncology; screening
تواريخ الأحداث: Date Created: 20240314 Latest Revision: 20240807
رمز التحديث: 20240807
DOI: 10.1002/pon.6322
PMID: 38483339
قاعدة البيانات: MEDLINE
الوصف
تدمد:1099-1611
DOI:10.1002/pon.6322